Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Early tumorigenesis is associated with the engagement of the DNA-damage checkpoint response (DDR). Cell proliferation and transformation induced by oncogene activation are restrained by cellular senescence. It is unclear whether DDR activation and oncogene-induced senescence (OIS) are causally linked. Here we show that senescence, triggered by the expression of an activated oncogene (H-RasV12) in normal human cells, is a consequence of the activation of a robust DDR. Experimental inactivation of DDR abrogates OIS and promotes cell transformation. DDR and OIS are established after a hyper-replicative phase occurring immediately after oncogene expression. Senescent cells arrest with partly replicated DNA and with DNA replication origins having fired multiple times. In vivo DNA labelling and molecular DNA combing reveal that oncogene activation leads to augmented numbers of active replicons and to alterations in DNA replication fork progression. We also show that oncogene expression does not trigger a DDR in the absence of DNA replication. Last, we show that oncogene activation is associated with DDR activation in a mouse model in vivo. We propose that OIS results from the enforcement of a DDR triggered by oncogene-induced DNA hyper-replication.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inhibition of DDR signalling kinases (ATM, ATR, CHK1 and CHK2) allows senescent cells to re-enter the cell cycle7,24,25”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [7]
In the citing paper
“Oncogene activation is a powerful inducer of cellular senescence. Oncogene expression triggers an initial hyperproliferative phase that is intrinsically associated with altered DNA replication, which eventually engages DDR pathways and causes senescence7,8,39”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [7]
In the citing paper
“In normal cells, however, oncogenic RAS causes genotoxic stress and senescence [ 57 , 58 ], inducing a SASP and thereby conferring complex cell-nonautonomous oncogenic activities.”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [57]
In the citing paper
“Indeed, most oncogenes that have been studied in the literature cause replication stress by increasing origin firing and triggering DNA damage [12, 29]”
From The Spi1/PU.1 transcription factor accelerates replication fork progression by increasing PP1 phosphatase in leukemia (2017) · cites this paper as [12]
In the citing paper
“It has been shown that one mechanism for the link between the initial mitotic reaction and senescence induction is the S-phase-associated DDR: The oncogenic stress drives increased DNA replication origins, leading to accumulation of incomplete replication intermediates, resulting in DNA damage and activation of the DDR kinases (ATM, ATR, CHK2, and CHK1) (Bartkova et al. 2006; Di Micco et al. 2006;”
From Cellular senescence and its effector programs (2014) · cites this paper as Di Micco et al. 2006
14 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Oncogenic activity of Cdc6 through repression of the INK4/ARF locus
Gonzalez, S., Klatt, P., Delgado, S., Conde, E., Lopez-Rios, F., Sanchez-Cespedes, M., Mendez, J., Antequera, F., & Serrano, M. (2006) · Nature · doi:10.1038/nature04585 · Cited by 186
RetractedA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Cited by
Items 601–700 of 1,011
Vitamin D/vitamin D receptor axis regulates DNA repair during oncogene-induced senescence
Graziano, S., Johnston, R., Deng, O., Zhang, J., & Gonzalo, S. (2016) · Oncogene · doi:10.1038/onc.2016.77 · Cited by 60
p16INK4a Regulates Cellular Senescence in PD-1-Expressing Human T Cells
Janelle, V., Neault, M., Lebel, M., Sousa, D. M. D., Boulet, S., Durrieu, L., Carli, C., Muzac, C., Lemieux, S., Labrecque, N., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.698565 · Cited by 67
Li, S., Kong, L., Meng, Y., Chen, C., Lemacon, D. S., Yang, Z., Tan, K., Cheruiyot, A., Lu, Z., & You, Z. (2023) · Molecular Cell · doi:10.1016/j.molcel.2022.12.034 · Cited by 64
Corpet, A., & Stucki, M. (2014) · Chromosoma · doi:10.1007/s00412-014-0469-6 · Cited by 63
Rass, U. (2013) · Chromosoma · doi:10.1007/s00412-013-0431-z · Cited by 61
“More pleiotropically acting endogenous replication stress, associated with oncogene activation, has been identified as a candidate driver in the development of cancer (Bartkova et al. 2005, 2006; Di Micco et al. 2006; Gorgoulis et al. 2005).”
BackgroundDNA Damage Response and Inflammatory Signaling Limit the MLL-ENL-Induced Leukemogenesis In Vivo
Takáčová, S., Slany, R. K., Bártková, J., Stránecký, V., Doležel, P., Lužná, P., Bártek, J., & Divoký, V. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.021 · Cited by 65
Reddy, J. P., Peddibhotla, S., Bu, W., Zhao, J., Haricharan, S., Du, Y. N., Podsypanina, K., Rosen, J. M., Donehower, L. A., & Li, Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910665107 · Cited by 63
Hubackova, S., Novakova, Z., Krejcikova, K., Kosar, M., Dobrovolna, J., Duskova, P., Hanzlikova, H., Vancurova, M., Barath, P., Bartek, J., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.15.12521 · Cited by 56
The Dual Roles of MYC in Genomic Instability and Cancer Chemoresistance
Kumari, A., Folk, W. P., & Sakamuro, D. (2017) · Genes · doi:10.3390/genes8060158 · Cited by 61
“Using rodent primary embryo fibroblasts as an in vitro model system, oncogenic foci formation can be experimentally achieved by the co-transfection of two independent oncogenes; one is a nuclear oncogene (such as c-MYC and adenovirus E1A) and the other is a cytoplasmic oncogene (such as activated RAS) [39,101].”
BackgroundInfluentialYu, X., Liu, Y., Yin, L., Peng, Y., Peng, Y., Gao, Y., Yuan, B., Zhu, Q., Cao, T., Xie, B., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0460-4 · Cited by 63
Radiotherapy-Induced Senescence and its Effects on Responses to Treatment
Tabasso, A. F. S., Jones, D. J. L., Jones, G. D. D., & Macip, S. (2019) · Clinical Oncology · doi:10.1016/j.clon.2019.02.003 · Cited by 63
DNA Replication Stalling Attenuates Tyrosine Kinase Signaling to Suppress S Phase Progression
Shields, B. J., Hauser, C., Bukczynska, P. E., Court, N. W., & Tiganis, T. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.003 · Cited by 64
Evangelou, K., Bartkova, J., Kotsinas, A., Pateras, I. S., Liontos, M., Velimezi, G., Kosar, M., Liloglou, T., Trougakos, I. P., Dyrskjot, L., et al. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.76 · Cited by 59
Senescence and the Aging Immune System as Major Drivers of Chronic Kidney Disease
Schroth, J., Thiemermann, C., & Henson, S. M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.564461 · Cited by 59
“…or irradiation Yentrapalli et al., 2013 Oncogenes and tumor suppressor genes Oncogene activation as well as suppression of tumor suppressor genes Di Micco et al., 2006 Oxidative stress Metabolic derived oxidative products induce DNA damage Ziegler et al., 2015 Mitochondrial dysfunction…”
BackgroundRegulation of Cdc45 in the cell cycle and after DNA damage
Broderick, R., & Nasheuer, H. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370926 · Cited by 60
Kawasumi, M., Lemos, B., Bradner, J. E., Thibodeau, R., Kim, Y.-S., Schmidt, M., Higgins, E., Koo, S.-W., Angle-Zahn, A., Chen, A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111378108 · Cited by 57
Multiple facets of p53 in senescence induction and maintenance
Johmura, Y., & Nakanishi, M. (2016) · Cancer Science · doi:10.1111/cas.13060 · Cited by 59
Defective Replication Stress Response Is Inherently Linked to the Cancer Stem Cell Phenotype
McGrail, D. J., Lin, C. C.-J., Dai, H., Mo, W., Li, Y., STEPHAN, C. C., Davies, P. J., Lu, Z., Mills, G. B., Lee, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.068 · Cited by 59
Cytokine loops driving senescence
Bártek, J., Hodný, Z., & Lukas, J. (2008) · Nature Cell Biology · doi:10.1038/ncb0808-887 · Cited by 61
The DNA-damage response: new molecular insights and new approaches to cancer therapy
Jackson, S. P. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370483 · Cited by 71
Cyclin-dependent kinase regulates the length of S phase through TICRR/TRESLIN phosphorylationPreprint
Sansam, C. G., Goins, D., Siefert, J. C., Clowdus, E. A., & Sansam, C. L. (2015) · Genes & Development · doi:10.1101/gad.246827.114 · Cited by 60
“Oncogenic mutations that abnormally accelerate DNA replication typically cause DNA damage during S phase, suggesting that the speed of S-phase progression is a hardwired property of a cell (Di Micco et al. 2006).”
The complex nature of fragile site plasticity and its importance in cancer
Sarni, D., & Kerem, B. (2016) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2016.03.017 · Cited by 59
Anacker, D. C., Aloor, H. L., Shepard, C., Lenzi, G. M., Johnson, B. A., Kim, B., & Moody, C. A. (2016) · Virology · doi:10.1016/j.virol.2016.09.028 · Cited by 60
“Increasing evidence supports the idea that oncogenes induce replication stress, especially those that promote uncontrolled S-phase entry (Bartkova et al., 2006; Di Micco et al., 2006; Halazonetis et al., 2008; Mallette et al., 2007).”
BackgroundGerosuppressant Metformin: less is more
Menendez, J. A., Cufí, S., Oliveras-Ferraros, C., Vellon, L., Joven, J., & Vazquez-Martin, A. (2011) · Aging · doi:10.18632/aging.100316 · Cited by 58
“It would be relevant to evaluate whether metformin coexposure may favour the “accelerated senescence” triggered in normal cells by the expression of mutant Ras or Raf (oncogene-induced senescence) and by some other forms of supraphysiological mitogenic signaling [130-132] getting stuck irrespective of senescenceinhibi…”
BackgroundThe replicometer is broken: telomeres activate cellular senescence in response to genotoxic stresses
Suram, A., & Herbig, U. (2014) · Aging Cell · doi:10.1111/acel.12246 · Cited by 60
Tetraploidy in cancer and its possible link to aging
Tanaka, K., Goto, H., Nishimura, Y., Kasahara, K., Mizoguchi, A., & Inagaki, M. (2018) · Cancer Science · doi:10.1111/cas.13717 · Cited by 61
“Aneuploidy promotes cellular senescence supposedly through DNA damage (Figure 1).(64,65) Cellular senescence works primarily as an anticancer mechanism by preventing the prolif-”
BackgroundBenedict, B., van Schie, J. J. M., Oostra, A. B., Balk, J. A., Wolthuis, R. M. F., Riele, H. T., & de Lange, J. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.01.024 · Cited by 58
The E3 ligase PIRH2 polyubiquitylates CHK2 and regulates its turnover
Bohgaki, M., Hakem, A., Halaby, M. J., Bohgaki, T., Li, Q., Bissey, P.-A., Shloush, J., Kislinger, T., Sanchez, O., Sheng, Y., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.7 · Cited by 56
Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo
Niida, H., Murata, K., Shimada, M., Ogawa, K., Ohta, K., Suzuki, K., Fujigaki, H., Khaw, A. K., Banerjee, B., Hande, M. P., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.218 · Cited by 62
Tanaka, H., Goto, H., Inoko, A., Makihara, H., Enomoto, A., Horimoto, K., Matsuyama, M., Kurita, K., Izawa, I., & Inagaki, M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.633891 · Cited by 60
The Shelterin Protein TRF2 Inhibits Chk2 Activity at Telomeres in the Absence of DNA Damage
Buscemi, G., Zannini, L., Fontanella, E., Lecis, D., Lisanti, S., & Delia, D. (2009) · Current Biology · doi:10.1016/j.cub.2009.03.064 · Cited by 64
“it ATM and Chk2 playing a key role in replicative- and oncogene-induced senescence [10, 11].”
He, X., & Zhang, P. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0422-1 · Cited by 59
“In dividing cells like cancer cells, DSBs are mainly caused by endogenous factors (endogenous DSBs, EDSBs), such as reactive oxygen species (ROS) and replication stress [37], and can be induced by activated oncogenes [38–41].”
Roberts, S. A., & Gordenin, D. A. (2014) · BioEssays · doi:10.1002/bies.201300140 · Cited by 56
Highly Aggressive Metastatic Melanoma Cells Unable to Maintain Telomere Length
Viceconte, N., Dheur, M.-S., Majerová, E., Pierreux, C. E., Baurain, J., van Baren, N., & Decottignies, A. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.046 · Cited by 54
AT-dinucleotide rich sequences drive fragile site formation
Sinai, M. I., Salamon, A., Stanleigh, N., Goldberg, T., Weiss, A. M., Wang, Y., & Kerem, B. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz689 · Cited by 62
“The integrated AT-DRS creates a novel fragile site To investigate the effect of the integrated AT-DRS on the chromosomal stability at the integration site under replication stress conditions, we treated cells from two different clones integrated with the pHPRThyg FRA16C with low concentrations of aphidicolin and caffe…”
InfluentialHelbling-Leclerc, A., Garcin, C., & Rosselli, F. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00764-5 · Cited by 61
“FANCD2 ectopic overexpression delays OIS progression without a major effect on p53 or p21 induction [93].”
BackgroundInfluentialCellular senescence or stemness: hypoxia flips the coin
Otero-Albiol, D., & Carnero, A. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02035-0 · Cited by 58
DNA double-strand break repair and development
Phillips, E. R., & McKinnon, P. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210877 · Cited by 64
“The DNA damage response is also a barrier to transformation, and if inactive in the face of replication stress, cellular transformation can occur (Bartkova et al., 2005, 2006; Braig et al., 2005; Di Micco et al., 2006).”
BackgroundRegulation of tissue‐ and stimulus‐specific cell fate decisions by p53 in vivo
Jackson, J. G., Post, S. M., & Lozano, G. (2011) · The Journal of Pathology · doi:10.1002/path.2783 · Cited by 53
Sin3B Expression Is Required for Cellular Senescence and Is Up-regulated upon Oncogenic Stress
Grandinetti, K. B., Jelinic, P., DiMauro, T., Pellegrino, J., Fernández Rodríguez, R., Finnerty, P. M., Ruoff, R., Bardeesy, N., Logan, S. K., & David, G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0537 · Cited by 54
Kurfürstová, D., Bártková, J., Vrtěl, R., Mičková, A., Burdová, A., Majera, D., Mistrík, M., Král, M., Santer, F. R., Bouchal, J., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.02.005 · Cited by 58
Cyclin E Deregulation and Genomic Instability
Teixeira, L. K., & Reed, S. I. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-6955-0_22 · Cited by 61
Ohtani, N. (2019) · The Journal of Biochemistry · doi:10.1093/jb/mvz055 · Cited by 57
Cdt1 and Geminin in cancer: markers or triggers of malignant transformation?
Petropoulou, C., Κοταντάκη, Π., Karamitros, D., & Taraviras, S. (2008) · Frontiers in bioscience · doi:10.2741/3018 · Cited by 59
“Recent studies provide evidence that activation of oncogenes in a precancerous lesion is accompanied by hyperproliferation and DNA hyper-replication (72, 73).”
BackgroundLi, B., Hou, D., Guo, H., Zhou, H., Zhang, S., Xu, X., Liu, Q., Zhang, X., Zou, Y., Gong, Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00315-4 · Cited by 54
Brambati, A., Colosio, A., Zardoni, L., Galanti, L., & Liberi, G. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00166 · Cited by 47
miR-30 disrupts senescence and promotes cancer by targeting both p16INK4A and DNA damage pathways
Su, W., Hong, L., Xu, X., HUANG, S. H., Herpai, D., Li, L., Xu, Y., Truong, L. N., Hu, W.-Y., Wu, X., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0358-1 · Cited by 57
“induced senescence [4], mediated by DNA damage responses triggered by DNA hyper-replication [5, 6].”
Loss of p53 suppresses replication-stress-induced DNA breakage in G1/S checkpoint deficient cells
Benedict, B., van Harn, T., Dekker, M., Hermsen, S., Kucukosmanoglu, A., Pieters, W., Delzenne-Goette, E., Dorsman, J. C., Petermann, E., Foijer, F., et al. (2018) · eLife · doi:10.7554/elife.37868 · Cited by 53
Completing genome replication outside of S phase
Bhowmick, R., Hickson, I. D., & Liu, Y. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.08.023 · Cited by 54
Sadaie, M., Dillon, C., Narita, M., Young, A. R. J., Cairney, C. J., Godwin, L. S., Torrance, C. J., Bennett, D. C., Keith, W. N., & Narita, M. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-01-0003 · Cited by 57
Snaps and mends: DNA breaks and chromosomal translocations
Javadekar, S. M., & Raghavan, S. C. (2015) · FEBS Journal · doi:10.1111/febs.13311 · Cited by 55
Cellular senescence in the tumor microenvironment and context‐specific cancer treatment strategies
Yasuda, T., Baba, H., & Ishimoto, T. (2021) · FEBS Journal · doi:10.1111/febs.16231 · Cited by 61
Breitenbach, M., Laun, P., & Jazwinski, S. M. (2011) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-2561-4 · Cited by 59
Lack of TRF2 in ALT cells causes PML-dependent p53 activation and loss of telomeric DNA
d’Alcontres, M. S., Méndez-Bermúdez, A., Foxon, J. L., Royle, N. J., & Salomoni, P. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703020 · Cited by 68
Chen, E., Ahn, J. S., Massie, C. E., Clynes, D., Godfrey, A. L., Li, J., Park, H. J., Nangalia, J., Silber, Y., Mullally, A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401873111 · Cited by 51
“Overexpression of the human papillomavirus E6/E7 oncoproteins and cyclin E drives transition from G1 to S phase under inappropriate circumstances, such as limiting levels of nutrients (14), and H-RasV12 causes increased activation of dormant origins and rereplication (26).”
BackgroundResultBartkova, J., Rajpert‐De Meyts, E., Skakkebæk, N. E., Lukas, J., & Bartek, J. (2007) · International Journal of Andrology · doi:10.1111/j.1365-2605.2007.00772.x · Cited by 53
Molecular Pathways: Targeting the Dependence of Mutant RAS Cancers on the DNA Damage Response
Grabocka, E., Commisso, C., & Bar‐Sagi, D. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0650 · Cited by 56
Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation
Ferrari, S., Vavassori, V., Canarutto, D., Jacob, A., Castiello, M. C., Omer, A., & Genovese, P. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.618378 · Cited by 57
“Moreover, even if some rare genotoxic event occurred, prompt restoration of the p53 pathway may be expected to counter-select cells that have acquired them before the occurrence of the subsequent hits necessary for oncogenic transformation (Di Micco et al., 2006; Bondar and Medzhitov, 2010).”
BackgroundThe complex interplay between aging and cancer
Trastus, L. A., & di Fagagna, F. D. (2025) · Nature Aging · doi:10.1038/s43587-025-00827-z · Cited by 65
“Ionizing radiation, UV light, genotoxic chemicals ...”
Senescence: the good the bad and the dysfunctional
Pazolli, E., & Stewart, S. A. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.12.002 · Cited by 59
Quantitative digital in situ senescence-associated β-galactosidase assay
Shlush, L. I., Itzkovitz, S., Cohen, A., Rutenberg, A., Berkovitz, R., Yehezkel, S., Shahar, H., Selig, S., & Skorecki, K. (2011) · BMC Cell Biology · doi:10.1186/1471-2121-12-16 · Cited by 49
“Other well studied forms of CS include oncogene-induced senescence [6-8], cell structure induced senescence related to dysfunctional Lamin A [9], and stress-induced premature senescence (SIPS), the latter most thoroughly studied in relation to oxidative stress [10-12].”
BackgroundSignificance of Cellular Senescence in Aging and Cancer
Grimes, A., & Chandra, S. (2009) · Cancer Research and Treatment · doi:10.4143/crt.2009.41.4.187 · Cited by 68
“Inactivation of DNA damage checkpoint response results in the development of transformed cells while its activation leads to senescence and to maintenance of oncogene induced senescence (68).”
BackgroundVerschuren, E. W., Ban, K. H.-K., Masek, M. A., Lehman, N. L., & Jackson, P. K. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00908-07 · Cited by 52
“These findings are in accordance with recent reports showing a correlation between oncogene-induced senescence in early tumors and a DNA hyperreplication response (3, 13).”
BackgroundResultA TRF1-controlled common fragile site containing interstitial telomeric sequences
Bosco, N., & de Lange, T. (2012) · Chromosoma · doi:10.1007/s00412-012-0377-6 · Cited by 58
“…lesions, aberrant stimulation of cell proliferation can induce DNA replication stress that preferentially targets common fragile sites (Bartkova et al. 2006; Gorgoulis et al. 2005; Di Micco et al. 2006; Tsantoulis et al. 2008; Bignell et al. 2010; Dereli-Oz et al. 2011; Bester et al. 2011).”
Pawlikowski, J. S., Adams, P. D., & Nelson, D. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.109728 · Cited by 70
p73 poses a barrier to malignant transformation by limiting anchorage‐independent growth
Beitzinger, M., Hofmann, L., Oswald, C., Beinoravičiūtė-Kellner, R., Sauer, M., Griesmann, H., Bretz, A. C., Burek, C., Rosenwald, A., & Stiewe, T. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.13 · Cited by 52
“In the BJ cells, high cell density might provide such an activating signal to E2F1 that is already present in many cancer cell lines due to constitutively active DNA damage signalling induced by oncogenic Ras or c-Met (Di Micco et al, 2006).”
BackgroundPC4 promotes genome stability and DNA repair through binding of ssDNA at DNA damage sites
Mortusewicz, O., Evers, B., & Helleday, T. (2015) · Oncogene · doi:10.1038/onc.2015.135 · Cited by 52
Wang, J.-Y., Wu, P.-K., Chen, P. C.-H., Lee, C.-W., Chen, W.-M., & Hung, S.-C. (2017) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0226 · Cited by 49
Chromá, K., Mistrík, M., Moudrý, P., Gurský, J., Liptay, M., Strauss, R., Škrott, Z., Vrtěl, R., Bártková, J., Kramara, J., et al. (2016) · Oncogene · doi:10.1038/onc.2016.392 · Cited by 53
He, Y., Zhao, Y., Wang, L., Bohrer, L. R., Pan, Y., Wang, L., & Huang, H. (2017) · Oncogene · doi:10.1038/onc.2017.353 · Cited by 53
Komseli, E.-S., Pateras, I. S., Krejsgaard, T., Stawiski, K., Rizou, S. V., Polyzos, A., Roumelioti, F.-M., Chiourea, M., Mourkioti, I., Paparouna, E., et al. (2018) · BMC Genomics · doi:10.1186/s12864-017-4375-1 · Cited by 51
“In parallel, at the molecular level an intense DDR response was noticed, which is in line with previous reports demonstrating a functional link between DDR and acquirement of senescence [33, 34, 64, 72, 74].”
ResultNutrient sensing, growth and senescence
Carroll, B., & Korolchuk, V. I. (2018) · The FEBS Journal · doi:10.1111/febs.14400 · Cited by 50
Diverse roles of RAD18 and Y-family DNA polymerases in tumorigenesis
Yang, Y., Gao, Y., Zlatanou, A., Tateishi, S., Yurchenko, V., Rogozin, I. B., & Vaziri, C. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1456296 · Cited by 53
“Some of the earliest papers describing OIS observed aberrant re-initiation of DNA synthesis multiple times each per cell cycle – a process usually termed ‘ re-replication ’ or ‘ hyper-replication ’ – in oncogene-expressing cells [53].”
Underappreciated Roles of DNA Polymerase δ in Replication Stress Survival
Fuchs, J., Cheblal, A., & Gasser, S. M. (2021) · Trends in Genetics · doi:10.1016/j.tig.2020.12.003 · Cited by 54
Diverse Roles of Cellular Senescence in Skeletal Muscle Inflammation, Regeneration, and Therapeutics
Saito, Y., & Chikenji, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.739510 · Cited by 57
“Accumulation of senescent cells is observed particularly in age-associated chronic inflammatory diseases, such as chronic kidney disease (Docherty et al., 2019), idiopathic pulmonary fibrosis (Schafer et al., 2017), diabetes (Palmer et al., 2019), atherosclerosis (Wang and Bennett, 2012),…”
BackgroundIGF-I enhances cellular senescence via the reactive oxygen species–p53 pathway
Handayaningsih, A. E., Takahashi, M., Fukuoka, H., Iguchi, G., Nishizawa, H., Yamamoto, M., Suda, K., & Takahashi, Y. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.140 · Cited by 58
Kilbey, A., Blyth, K., Wotton, S., Terry, A., Jenkins, A., Bell, M., Hanlon, L., Cameron, E. R., & Neil, J. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-3016 · Cited by 51
“Our observations do not exclude the existence of multiple blocks to cell cycle progression in H-Ras–transduced cells but are in accord with recent studies showing that oncogene-induced senescence and associated DNA damage can result in activation of S-G2-M checkpoints (34, 35).”
Myc Down-regulation as a Mechanism to Activate the Rb Pathway in STAT5A-induced Senescence
Mallette, F. A., Gaumont-Leclerc, M.-F., Huot, G., & Ferbeyre, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707074200 · Cited by 51
The impact of ageing mechanisms on musculoskeletal system diseases in the elderly
Cai, Y., Han, Z., Cheng, H., Li, H., Wang, K., Chen, J., Liu, Z., Xie, Y., Lin, Y., Zhou, S., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1405621 · Cited by 57
Oncogene-induced senescence: An essential role for Runx
Terry, A., Cameron, E., Neil, J., & Kilbey, A. (2008) · Cell Cycle · doi:10.4161/cc.6368 · Cited by 46
Lin, T.-Y., Cheng, Y.-C., Yang, H.-C., Lin, W.-C., Wang, C.-C., Lai, P.-L., & Shieh, S.-Y. (2011) · Oncogene · doi:10.1038/onc.2011.491 · Cited by 56
“…of this notion, senescence and senescence-associated secretion have been observed in precancerous lesions (Chen et al., 2005; Bartkova et al., 2006; Majumder et al., 2008) and, in some cases, are accompanied by activation of DNA-damage signaling (Bartkova et al., 2005, 2006; Di Micco et al., 2006).”
BackgroundTelomere Dysfunction, Chromosomal Instability and Cancer
Meena, J. K., Rudolph, K. L., & Güneş, Ç. (2015) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-20291-4_3 · Cited by 61
WSB1 overcomes oncogene-induced senescence by targeting ATM for degradation
Kim, J. J., Lee, S. B., Yi, S. Y., Han, S.-A., Kim, S., Lee, J., Tong, S., Yin, P., Gao, B., Zhang, J., et al. (2016) · Cell Research · doi:10.1038/cr.2016.148 · Cited by 58
AKT overactivation can suppress DNA repair via p70S6 kinase-dependent downregulation of MRE11
Piscitello, D., Varshney, D., Lilla, S., Vizioli, M. G., Reid, C., Gorbunova, V. A., Seluanov, A., Gillespie, D. A., & Adams, P. D. (2017) · Oncogene · doi:10.1038/onc.2017.340 · Cited by 54
The human nucleoporin Tpr protects cells from RNA-mediated replication stress
Košař, M., Giannattasio, M., Piccini, D., Maya‐Mendoza, A., García-Benítez, F., Bártková, J., Barroso, S. I., Gaillard, H., Martini, E., Restuccia, U., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24224-3 · Cited by 55
Cell senescence as both a dynamic and a static phenotype
Young, A. R. J., Narita, M., & Narita, M. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_1 · Cited by 50
An mRNA expression-based signature for oncogene-induced replication-stress
Llobet, S. G., Bhattacharya, A., Everts, M., Kok, K., van der Vegt, B., Fehrmann, R. S. N., & van Vugt, M. A. T. M. (2022) · Oncogene · doi:10.1038/s41388-021-02162-0 · Cited by 53
The DNA damage checkpoint: A tale from budding yeast
Pizzul, P., Casari, E., Gnugnoli, M., Rinaldi, C., Corallo, F., & Longhese, M. P. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.995163 · Cited by 59
Molecular mechanisms of ageing and related diseases
Liu, J. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12247 · Cited by 56
“A pro-OIS post-translational modification mechanism has recently been identified for the multifunctional acetyltransferase tat-interactive protein 60 (Tip60) and protein kinase p38-regulated/activated protein kinase (PRAK).111 Following activation by ras, p38 induces Tip60 acetyltransferase activity through phosphoryl…”
BackgroundInfluentialMolecular Mechanisms Underlying Hepatocellular Carcinoma
Merle, P., & TREPO, C. G. (2009) · Viruses · doi:10.3390/v1030852 · Cited by 54
Failure of cell cleavage induces senescence in tetraploid primary cells
Panopoulos, A., Pacios-Bras, C., Choi, J., Mythili, Y., Sussman, M. A., Fotedar, R., & Margolis, R. L. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-03-0844 · Cited by 52
“…critically short telomeres is preceded by a period of hyperproliferation and accumulation of DNA damage, accompanied by a robust DNA damage checkpoint response (Takai et al., 2003; Bartkova et al., 2006; Di Micco et al., 2006; Nardella et al., 2011), which is followed by late onset of senescence.”
Interplay Between DNA Tumor Viruses and the Host DNA Damage Response
McFadden, K., & Luftig, M. A. (2013) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-37765-5_9 · Cited by 54
Wu, C.-L., Wang, Y., Jin, B., Chen, H., Xie, B., & Mao, Z.-B. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.661785 · Cited by 53
Impact of Replication Stress in Human Papillomavirus Pathogenesis
Moody, C. A. (2018) · Journal of Virology · doi:10.1128/jvi.01012-17 · Cited by 52
“Oncogene-induced RS triggers a sustained DDR that results in apoptosis or senescence, acting as an intrinsic barrier to tumorigenesis (41, 42).”
BackgroundSchaefer, T., Steiner, R., & Lengerke, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144902 · Cited by 55
Srinivas, U. S., Dyczkowski, J., Beißbarth, T., Gaedcke, J., Mansour, W. Y., Borgmann, K., & Dobbelstein, M. (2015) · Oncotarget · doi:10.18632/oncotarget.3728 · Cited by 52
“Overexpression or activation of genes that enhance proliferation, such as cyclin E and Ras [6, 7], or treatment with nucleoside analogs, hydroxyurea, or 5-FU [8-10] further exacerbate this stress condition [11].”
Tu, Z., Zhuang, X., Yao, Y., & Zhang, R. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01744-12 · Cited by 54
“In addition, senescence induced by oncogenic RAS is characterized by a DNA damage response (10) and is accompanied by the accumulation of markers of DNA damage such as upregulation of H2AX protein expression and increased formation of H2AX DNA damage foci (10, 11).”
BackgroundMyc-Dependent Genome Instability and Lifespan in Drosophila
Greer, C., Lee, M., Westerhof, M., Milholland, B., Spokony, R. F., Vijg, J., & Secombe, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074641 · Cited by 52
“Oncogene-induced senescence can occur because replication stress triggers the DNA damage response [52].”
BackgroundZheng, H., Seit-Nebi, A., Han, X., Aslanian, A., Tat, J., Liao, R., Yates, J. R., & Sun, P. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.04.013 · Cited by 48
“Tip60 mediates DNA damage responses induced by genotoxic agents or oncogenes (Gorrini et al., 2007; Sun et al., 2005), and DNA damage is an intermediate step in ras-induced senescence (Bartkova et al., 2006; Di Micco et al., 2006).”
BackgroundORF73-Null Murine Gammaherpesvirus 68 Reveals Roles for mLANA and p53 in Virus Replication
Forrest, J. C., Paden, C. R., ALLEN, R. D., Collins, J. T., & Speck, S. H. (2007) · Journal of Virology · doi:10.1128/jvi.00111-07 · Cited by 58
“Moreover, as oncogene expression or deregulated expression of cell cycle control proteins, including cyclin E, can trigger p53 activation and cell cycle arrest (6, 20, 39, 43, 59), it is tempting to speculate that, while partially rescuing 73.”
Background
Metadata
- Authors
- Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., Maestro, R., Giuseppe Pelicci, P., & d’Adda di Fagagna, F.
- Affiliations
- IFOM (IT)
- European Institute of Oncology (IT)
- Centro di Riferimento Oncologico (IT)
- Institut Pasteur (FR)
- Genomic Vision (France) (FR)
- Venue
- Nature
- Published
- 2006-11
- Volume
- 444
- Issue
- 7119
- Pages
- 638-642
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2121371748
- Cited by
- 1,821
- References
- 30
- Citations by year
- 2026: 50 · 2025: 58 · 2024: 62 · 2023: 76 · 2022: 80 · 2021: 118 · 2020: 84 · 2019: 81 · 2018: 104 · 2017: 84 · 2016: 110 · 2015: 89 · 2014: 118 · 2013: 107 · 2012: 115
- FWCI
- 58.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- oncogene-induced senescence, DNA damage response, H-Ras V12, origin of replication, DNA replication fork progression, cell transformation, carcinogenesis, senescence markers, DNA combing
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Cells, Cultured, DNA Replication, Genetic Markers, Humans, Genes, ras, Cellular Senescence, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.